Australia Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others
- Published: August 2011
- Region: Australia
The broad ‘health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.
Global electrophysiology devices market forecasts to reach at US$4.4 billion by 2015 at a CAGR of 9.7% during the analysis period 2009-2015. The North American segment accounts for nearly 35% of the global value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing region with a CAGR of 10.8% driving a market value of US$1.1 billion by 2015.
Among the product types, diagnostic electrophysiology catheters account for more than 65% of the market value while laboratory devices and ablation catheters round off to 35%. On a global scale, projections for conventional electrophysiology catheters segment indicate a close to 50% of the diagnostic EP market by 2015 leaving the rest of the market to advanced and ultrasound types. Considering the ablation catheters types, RF ablation catheters segment indicate a close to 40% by 2015 while cryo, laser, microwave and other types adds up to the remaining 60%. In the case of EP laboratory devices, X-ray segment indicate a close to 33% by 2015 and the rest of the portion is filled by 3D mapping, recording, remote steering, intra cardiac ECG and RF ablation generators.
The report ‘Global Electrophysiology (EP) Devices - Market Growth Analysis, 2009-2015' reviews the latest trends in Electrophysiology devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.
The report primarily focuses on:
- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand Of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies
The report covers the market analysis by product types. The subdivisions are as:
1. Diagnostic Electrophysiology Catheters
a. Conventional EP Diagnostic Catheters (fixed and steerable)
b. Advanced EP Diagnostic Catheters (loop and other)
c. Ultrasound EP Diagnostic Catheters
2. EP Laboratory Devices
a. X-Ray Systems
b. 3D Mapping Systems
c. EP Recording Systems
d. Remote Steering Systems
e. Intracardiac Echocardiography Systems
f. Radiofequency (RF) Ablation Generators
3. EP Ablation Catheters
a. Radiofequency (RF) EP Ablation Catheters (Conventional & Irrigated-Tip)
b. Cryoablation EP Catheters
c. Laser Ablation Systems
d. Navigational Advanced Mapping Accessories
e. Microwave Ablation
The period considered for the study analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 314 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. SHOW LESS READ MORE >
- Abbott Vascular Devicesatricure, Inc
- Abiomed, Inc.
- Advansource Biomaterials
- Aga Medical Corporation
- Atrium Medical Corp.
- Ats Medical, Inc.
- Biophan Technologies, Inc.
- Biosense Webster, Inc.
- Boston Scientific Corp
- Cardiac Science Corp.
- Cardiacassist, Inc.
- Cardica, Inc.
- Cardiomems, Inc.
- Cook Group Incorporated
- Cordis Corporation
- Cryolife Inc.
- Idev Technologies
- Medtronic, Inc.